Stem cell mobilization by hyperbaric oxygen

Read white paper here about Stem cell mobilization by hyperbaric oxygen

We hypothesized that exposure to hyperbaric oxygen (HBO2) would mobilize stem/progenitor cells
from the bone marrow by a nitric oxide (
NO) -dependent mechanism. The population of CD34
cells in the peripheral circulation of humans doubled in response to a single exposure to 2.0 atmospheres absolute (ATA) O2 for 2 h. Over a course of 20 treatments, circulating CD34
cells increased eightfold, although the overall circulating white cell count was not significantly increased. The number of colony-forming cells (CFCs) increased from 16 2 to 26 3 CFCs/100,000 monocytes plated. Elevations in CFCs were entirely due to the CD34
subpopulation, but increased cell growth only occurred in samples obtained immediately post-treatment. A high proportion of progeny cells express receptors for vascular endothelial growth factor-2 and for stromal-derived growth factor. In mice, HBO2 increased circulating stem cell factor by 50%, increased the number of circulating cells expressing stem cell antigen-1 and CD34 by 3.4-fold, and doubled the number of CFCs. Bone marrow
NO concentration increased by 1,008 255 nM in association with HBO2. Stem cell mobilization did not occur in knockout mice lacking genes for endothelial
NO synthase. Moreover, pretreatment of wild-type mice with a
NO synthase inhibitor prevented the HBO2-induced elevation in stem cell factor and circulating stem cells. We conclude that HBO2 mobilizes stem/ progenitor cells by stimulating
NO synthesis.